Gary Hennerberg
Director/Board Member at FINDIT
Net worth: 739 625 $ as of 2024-04-29
Gary Hennerberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FINDIT | Director/Board Member | 2024-03-07 | - |
| Corporate Secretary | 2024-03-07 | - |
Career history of Gary Hennerberg
Former positions of Gary Hennerberg
| Companies | Position | Start | End |
|---|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Director/Board Member | 2016-04-30 | - |
| Sales & Marketing | 2016-04-30 | - |
Training of Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 2 |
| Sales & Marketing | 1 |
| Corporate Secretary | 1 |
Sectoral
| Consumer Services | 2 |
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FINDIT | Technology Services |
| Private companies | 1 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
- Stock Market
- Insiders
- Gary Hennerberg
- Experience
